PARIS - NicOx SA and Pfizer Inc. formed a deal in a specific, but undisclosed, field covering a selection of nitric oxide-donating compounds patented by NicOx. (BioWorld International)

PARIS - Immuno-Designed Molecules SA proposed an IPO on the Nouveau Marche of the Euronext stock exchange in Paris last week, offering 8.1 million shares at €10.50 to €12.20 per share. (BioWorld International)

PARIS - Immuno-Designed Molecules SA proposed an IPO on the Nouveau Marche of the Euronext stock exchange in Paris last week, offering 8.1 million shares at €10.50 to €12.20 per share. (BioWorld International)